Citizens Financial Group’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$812K Buy
59,953
+4,747
+9% +$56.8K 0.01% 502
2026
Q1
$331K Buy
+55,206
New +$415K ﹤0.01% 659
2023
Q2
Sell
-9,221
Closed -$217K 447
2023
Q1
$217K Buy
9,221
+247
+3% +$6.63K 0.01% 425
2022
Q4
$251K Buy
+8,974
New +$229K 0.01% 373

Other funds holding OGN

Citizens Financial Group's OGN Position: Q2 2026 in Review

Citizens Financial Group increased its Organon & Co (OGN) stake by 8.6% in Q2 2026, buying an estimated $56.8K and bringing the position to 59,953 shares worth $812K. The position accounts for 0.01% of the portfolio, ranked #502.

Citizens Financial Group first reported a position in OGN in Q4 2022 and has held it in 4 quarters since. 627 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

  • Citizens Financial Group held 59,953 shares of Organon & Co worth $812K as of Q2 2026.
  • Citizens Financial Group bought 4,747 Organon & Co shares in Q2 2026, an estimated $56.8K.
  • Organon & Co made up 0.01% of Citizens Financial Group's portfolio in Q2 2026, its #502 holding.
  • Citizens Financial Group first reported a position in Organon & Co in Q4 2022 and has held it in 4 quarters since.
  • 627 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on Citizens Financial Group's 13F filing for Q2 2026, filed 7 Aug 2026.